{
    "medicine_id": "c83d1f4b4a81d1d472ed3ef46c0e18e20ecb5d8c",
    "platform_id": "DB06642",
    "metadata": {
        "name": "Ampyra 10 mg 1 Tablet film coated extended release",
        "composition": "10 mg 1 Bevasiranib",
        "clinical_particulars": {
            "therapeutic_indications": "Investigated for use treatment in macular degeneration and diabetic retinopathy",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Bevasiranib represents the first drug in a promising new class of experimental medical treatments It is a small interfering RNA siRNA drug which silences the genes that produce Vascular Endothelial Growth Factor VEGF a protein that promotes blood vessel growth The treatment slows the growth and leakage of abnormal blood vessels that are associated with the wet form of macular degeneration The drug is injected directly into the eye",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}